Veeda Oncology, the subsidiary of one of the leading Global CRO's in India, Veeda Clinical Research, has completed the acquisition of Biologie et Industrie (B&I), an Oncology CRO founded in 1984, based in Paris, France.

Veeda Oncology is a global Oncology CRO with operations in India, Eastern Europe, Western Europe and the US. The company is a full service oncology CRO for phase I through phase IV studies with the unique capability of providing rapid and strong global patient accrual with an effective cost structure. Veeda Oncology feels that the acquisition of B&I truly strengthens Veeda Oncology's capabilities. The acquisition of B&I, with over 20 years of oncology CRO experience, significantly compliments Veeda Oncology's capability within mainland Europe.

Veeda Clinical Research is a full service global CRO specializing in the early clinical development of drugs. With state-of-the-art facilities in the UK, India, Germany, Belgium and France it provides a full range of services in phase I and IIa clinical research, delivering expert, cost effective research solutions to the Pharmaceutical and Biotechnology Industries worldwide.